Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

89.30
Delayed Data
As of Dec 08
 +5.57 / +6.65%
Today’s Change
72.20
Today|||52-Week Range
121.75
+13.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Operating ActivitiesNet Income / Starting Line140.7M143.0M126.6M141.4M
 
 
 
 
 
Depreciation14.5M15.9M18.0M18.2M
 
 
 
 
 
Total Other Cash Flow2.3M3.6M24.1M-2.9M
 
 
 
 
 
Funds From Operations63.6M162.7M168.7M153.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-40.2M55.6M-21.6M-52.0M
 
 
 
 
 
Net Cash Flow - Operating Activities103.8M107.1M190.3M205.9M
 
 
 
 
 
 
InvestingIncrease In Investments-105.3M-231.9M-404.6M-291.7M
 
 
 
 
 
Decrease In Investments181.3M302.7M139.4M347.7M
 
 
 
 
 
Capital Expenditures-37.5M-27.7M-37.1M-48.1M
 
 
 
 
 
Net Assets From Acquisitions -11.5M0.000.000.00
 
 
Other Investing - Uses1.7M0.000.000.00
 
 
Other Investing - Sources--4.2M300.0K-3.8M
 
 
 
 
Net Cash Flow Investing27.3M47.3M-343.1M3.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings10.7M9.7M6.2M8.7M
 
 
 
 
 
Long Term Debt Reduction-10.7M-9.5M-9.8M-6.4M
 
 
 
 
 
Net Proceeds Stock Sale27.2M19.5M25.1M38.1M
 
 
 
 
 
Common Preferred Redeemed-100.0M-344.1M-36.6M-200.0K
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing14.2M12.8M24.4M19.4M
 
 
 
 
 
Other Uses - Financing1.1M57.5M-22.4M-4.2M
 
 
 
 
 
Net Cash Flow - Financing-59.7M-369.1M31.7M63.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash900.0K-2.3M-10.4M1.5M
 
 
 
 
 
 
Net Change In Cash71.4M-214.7M-121.1M273.6M